The present invention relates to the design, synthesis, and biological study of multi-targeted Ubenimex pro-drug derivative. More particularly, provided in the present invention is a compound as shown by general structural formula (I) (wherein the definition of R is shown in the description). The derivative is a multi-targeted compound obtained by binding an aminopeptidase (APN / CD13) inhibitor, Ubenimex, with some anti-tumor drugs already on the market through an ester bond or amide bond, and is suitable for use as an anti-tumor drug for the treating various malignant tumors, and is especially suitable for treating various solid tumors.
本发明涉及多靶点
乌苯美司原药衍
生物的设计、合成和
生物学研究。更具体地说,本发明提供了一种如通式结构式(I)所示的化合物(其中 R 的定义如描述所示)。该衍
生物是将
氨肽酶(A
PN / CD13)
抑制剂 Ubenimex 与市场上已有的一些
抗肿瘤药物通过酯键或酰胺键结合而得到的多靶点化合物,适用于作为治疗各种恶性肿瘤的
抗肿瘤药物,尤其适用于治疗各种实体瘤。